SCOTTSDALE, AZ – May 5th, 2026 – SimonMed, a national outpatient imaging provider and leader in radiology innovation and longevity health technology, today announced the expansion of its AI-enabled imaging platform, embedding advanced, FDA-cleared technologies directly into routine diagnostic exams across its nationwide network.
The expansion reflects a broader shift in healthcare from imaging as a one-time diagnostic test to a continuous source of preventive insight, enabling earlier detection and personalized risk assessments.
The new offerings—Calcium Score+, CT Bone Density, and MR Lumbar Spine+—apply AI to standard imaging exams, providing additional clinical insights from scans patients are already undergoing, without requiring extra scan time or radiation exposure.
Patients who opt into these services receive results through SimonMed’s Digital Health Platform, an interactive, mobile-first experience designed to make complex findings easier to understand and act on. Reports include clear summaries, visual explanations, guided next steps, and one-click access to a patient navigator who can support follow-up care and coordination.
“AI is accelerating a fundamental shift in healthcare, from reacting to disease to managing health over time,” said Dr. John Simon, CEO and Founder of SimonMed. “By embedding AI directly into routine imaging, we’re able to extract more meaningful insights from exams patients are already having and make those insights easier for patients to understand and act on.”
Calcium Score+ and CT Bone Density provide additional insight into heart and bone health—two leading drivers of long-term risk—from CT scans patients are already receiving. Both cardiovascular disease and bone loss often develop silently, progressing without symptoms until advanced stages. By unlocking additional insights from existing imaging, SimonMed enables earlier identification of risk and supports more proactive care.
Calcium Score+ enhances traditional coronary calcium scoring with AI-enabled analysis and a more guided reporting experience, helping quantify calcified plaque in the coronary arteries which is an established marker of cardiovascular risk from existing CT images.
CT Bone Density uses AI to assess bone mineral density opportunistically from CT scans that include the spine, enabling evaluation of bone health without the need for a dedicated DEXA exam. This approach can help identify osteopenia and osteoporosis in patients who may not otherwise be screened.
Both services can be added, individually or together, to non-contrast CT chest exams, including lung cancer screening. CT Bone Density may also be applied to abdomen and pelvis CT exams, expanding opportunities to assess fracture risk across a broader patient population.
MR Lumbar Spine+ applies FDA-cleared AI to standard lumbar MRI exams, transforming complex imaging into quantitative measurements, severity grading, and annotated visualizations. The result is more standardized, objective insights to support both clinical interpretation and patient understanding, without additional scan time or workflow disruption.
“Imaging has always been one of the most powerful tools in medicine, but for too long its value has been locked inside reports that patients struggle to act on,” said Dr. Sean Raj, Chief Medical Officer and Chief Innovation Officer at SimonMed. “What we’ve built is one of the most comprehensive AI platforms in outpatient imaging – bringing FDA-cleared technologies directly into routine care, at scale, across the country. We’re not just adding AI, we’re fundamentally redefining how imaging drives earlier detection, personalized risk insight, and proactive health.”
SimonMed’s AI platform is designed to integrate seamlessly into routine workflows, enabling advanced diagnostics to be delivered in community-based settings, not just academic centers. By scaling AI across its national footprint, SimonMed is expanding access to more advanced, data-driven insights for millions of patients each year.
These new offerings are part of SimonMed’s broader strategy to build an integrated, AI-driven imaging ecosystem, where advanced analytics, patient engagement, and preventive screening come together to support earlier detection and more continuous care.
The expansion also complements SimonMed Longevity, the company’s preventive imaging division, which combines whole-body MRI with multi-modality screening to help patients establish a baseline, track changes over time, and identify risk earlier—when intervention can have the greatest impact.
